0001127602-19-023025.txt : 20190628
0001127602-19-023025.hdr.sgml : 20190628
20190628162419
ACCESSION NUMBER: 0001127602-19-023025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190626
FILED AS OF DATE: 20190628
DATE AS OF CHANGE: 20190628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thompson Tommy G
CENTRAL INDEX KEY: 0001324863
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 19929699
MAIL ADDRESS:
STREET 1: 7711 CARONDELET
CITY: ST. LOUIS
STATE: MO
ZIP: 63105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-06-26
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001324863
Thompson Tommy G
1040 SPRING ST.
SILVER SPRING
MD
20910
1
Common Stock
2019-06-26
4
M
0
1870
0
A
21940
D
Stock Options
76.36
2019-06-26
4
A
0
12610
0
A
2020-06-26
2029-06-26
Common Stock
12610
12610
D
Restricted Stock Units
0
2019-06-26
4
M
0
1870
0
D
Common Stock
1870
0
D
Shares received upon vesting of restricted stock units on June 26, 2019. Restricted stock units converted on a one-for-one basis into shares of common stock.
Annual non-employee director grant of stock options, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders.
Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.
Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares.
/s/ John S. Hess, Jr. under Power of Attorney
2019-06-28